These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36184015)

  • 1. In vitro and in vivo efficacy of minocycline-based therapy for Elizabethkingia anophelis and the impact of reduced minocycline susceptibility.
    Yang YS; Huang TW; Huang YC; Huang WC; Hsu SY; Wu HC; Chen FJ; Shang HS; Sytwu HK; Kuo SC
    Int J Antimicrob Agents; 2022; 60(5-6):106678. PubMed ID: 36184015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and In Vivo Antimicrobial Activities of Vancomycin and Rifampin against
    Lin IF; Lai CH; Lin SY; Lee CC; Lee NY; Liu PY; Yang CH; Huang YH; Lin JN
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069334
    [No Abstract]   [Full Text] [Related]  

  • 3. Biofilm formation and antibiotic sensitivity in
    Hu S; Lv Y; Xu H; Zheng B; Xiao Y
    Front Cell Infect Microbiol; 2022; 12():953780. PubMed ID: 35967866
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic Combination to Effectively Postpone or Inhibit the In Vitro Induction and Selection of Levofloxacin-Resistant Mutants in
    Lee CC; Lai CH; Yang CH; Huang YH; Lin JN
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics and in vitro effects of antimicrobial combinations on planktonic and biofilm forms of Elizabethkingia anophelis.
    Tang HJ; Lin YT; Chen CC; Chen CW; Lu YC; Ko WC; Chen HJ; Su BA; Chang PC; Chuang YC; Lai CC
    J Antimicrob Chemother; 2021 Apr; 76(5):1205-1214. PubMed ID: 33532826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis.
    Lin JN; Lai CH; Yang CH; Huang YH; Lin HH
    J Antimicrob Chemother; 2018 Sep; 73(9):2497-2502. PubMed ID: 29846598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis.
    Lee YL; Hsueh PR
    Curr Opin Infect Dis; 2023 Dec; 36(6):481-494. PubMed ID: 37548375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against
    Lin JN; Lai CH; Huang YH; Yang CH
    Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33801839
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial Susceptibility of
    Comba IY; Schuetz AN; Misra A; Friedman DZP; Stevens R; Patel R; Lancaster ZD; Shah A
    J Clin Microbiol; 2022 Jun; 60(6):e0254121. PubMed ID: 35510517
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods.
    Kuo SC; Tan MC; Huang WC; Wu HC; Chen FJ; Liao YC; Wang HY; Shiau YR; Lauderdale TL
    J Antimicrob Chemother; 2021 Feb; 76(3):653-658. PubMed ID: 33258923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance in carbapenem-resistant Elizabethkingia anophelis: phenotypic and genotypic characteristics of clinical isolates with topoisomerase mutations and comparative genomic analysis.
    Jian MJ; Cheng YH; Chung HY; Cheng YH; Yang HY; Hsu CS; Perng CL; Shang HS
    J Antimicrob Chemother; 2019 Jun; 74(6):1503-1510. PubMed ID: 30830171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Phylogeny and Drug Resistance Mechanisms of
    Larkin PMK; Mortimer L; Malenfant JH; Gaynor P; Contreras DA; Garner OB; Yang S; Allyn P
    Microb Drug Resist; 2021 Sep; 27(9):1259-1264. PubMed ID: 33656389
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutant Prevention Concentrations of Ciprofloxacin and Levofloxacin and Target Gene Mutations of Fluoroquinolones in Elizabethkingia anophelis.
    Lin IF; Lai CH; Lin SY; Lee CC; Lee NY; Liu PY; Yang CH; Huang YH; Lin JN
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0030122. PubMed ID: 35708332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre study evaluating matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically isolated Elizabethkingia species and analysis of antimicrobial susceptibility.
    Cheng YH; Perng CL; Jian MJ; Cheng YH; Lee SY; Sun JR; Shang HS
    Clin Microbiol Infect; 2019 Mar; 25(3):340-345. PubMed ID: 29689427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibiotic resistance and pathogenicity of a multidrug-resistant Elizabethkingia anophelis isolate.
    Wang M; Gao H; Lin N; Zhang Y; Huang N; Walker ED; Ming D; Chen S; Hu S
    Microbiologyopen; 2019 Nov; 8(11):e804. PubMed ID: 30891912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
    Chang TY; Chen HY; Chou YC; Cheng YH; Sun JR
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2045-2052. PubMed ID: 31352669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis Isolated in Taiwan.
    Lin JN; Lai CH; Yang CH; Huang YH
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30545016
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative Analysis of Gradient Diffusion and Disk Diffusion with Agar Dilution for Susceptibility Testing of
    Chiu CT; Lai CH; Huang YH; Yang CH; Lin JN
    Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33923659
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic combinations of clarithromycin with doxycycline or minocycline reduce the emergence of antimicrobial resistance in Rhodococcus equi.
    Erol E; Shaffer CL; Lubbers BV
    Equine Vet J; 2021 Sep; ():. PubMed ID: 34480367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
    Yang H; Chen G; Hu L; Liu Y; Cheng J; Ye Y; Li J
    J Microbiol Immunol Infect; 2018 Feb; 51(1):70-75. PubMed ID: 26906264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.